Thanks so much for this Sera! I think you’re right — however many good people and even “good chapters” there may be at the grassroots, the national organization is so thoroughly captured by the pharmaceutical industry that it’s hard to even wrap your mind around. As a matter of fact, the industry relies on NAMI to speak for them, making claims for their products that they can’t legally make, and saying things that would be spotted as self-serving if the industry said them. Here’s the link you may have been searching for BTW, to get NAMI’s major corporate contributors: https://www.nami.org/About-NAMI/Our-Finances/Major-Foundation-Corporate-Sponsorships Their biggest contributor of late — $575K to be the national Premier Sponsor of NAMI’s fundraising walks — is Alkermes. I know. You never heard of it. Their business? Depot injections — which in 90% of cases are used for involuntary treatment. Alkermes makes Aristada, a 90-day depot Abilify injection, and Vivitrol, a 30-day naltrexone depot injection for opioid addicts which is being heavily marketed to prisons. They also own the patents on depot-injection technology used by several other companies. Prior to that the National NAMI Sugar Daddy Extraordinaire was Otsuka, makers of Abilify and Abilify Maintena (depot injection). The scandal-plagued for-profit hospital chain UHS (Universal Health Services) has given National NAMI $85K a year for the past few years. Their local hospitals have also formed close relationships with NAMI in numerous cities. In short, NAMI’s drug-money problem has not eased up at all in the past few years — if anything it has deepened. And it needs to be called out. They are an 800-lb gorilla in the media and PR field, with an awe-inspiring power to promote certain agendas and shut down others.